Abstract:Objective To explore the expression of ZNF217 in tissues of colon cancer (CRC), investigate the association of the expression levels of ZNF217 and clinicopathological features of CRC patients, and analyze the relevance of ZNF217 and survival and prognosis of CRC patients. Methods Expressions of ZNF217 were analyzed by immunohistochemistry in 84 CRC patients. Spearman's rank test, K-M survival curves, and Cox proportional hazards risk were conducted to analyze the clinical relevance of ZNF217 in CRC. Results Immunohistochemistry revealed that the positive rate of ZNF217 was upregulated in CRC tissues compare with adjacent tissues. Spearman rank correlation showed that positive ZNF217 expression was significantly associated with TNM stage, lymph node status and venous invasion of CRC patients. Kaplan-Meier curves showed that positive ZNF217 expression was inversely correlated with 5 years overall and progression-free survival time of CRC patients. Cox proportional hazards risk analysis revealed that ZNF217 was an independent prognostic factor for CRC. Conclusions ZNF217 expression is upregulated in tissues of CRC, and ZNF217 is a potential survival and prognosis biomarker in CRC.